Fucoidan is a natural polysaccharide that is found in the cell wall of various species of brown seaweed such as mozuku, kombu, limumoui, bladderwrack and wakame. Various forms of fucoidan have also been recognized in some marine invertebrates such as sea urchins and sea cucumbers. The brown seaweeds containing fucoidan are widely consumed as part of the normal diet in East Asia, particularly Japan, China and Korea.

fuco immune allergy research group conners clinic
The anti-cancer property of fucoidan has been demonstrated in vivo and in vitro in different types of cancers. Fucoidan works through various mechanisms such as induction of cell cycle arrest, apoptosis and immune system activation – all needed to battle cancer. Additional activities of fucoidan have been reported that may be linked to the observed anti-cancer properties and these include induction of inflammation through immune system, oxidative stress and stem cell mobilization.

There is a wide variety of cancer types yet, all share some common cellular and molecular behaviors. Most of the chemotherapeutic agents used in cancer treatment are designed to target common deregulated mechanisms within cancer cells. Many healthy tissues are also affected by the cytotoxic effects of these chemical agents. It also has beneficial effects as it can protect against toxicity associated with chemotherapeutic agents and radiation. Thus the synergistic effect of fucoidan with current anti-cancer agents is of considerable interest.

Fuco-Immune contains Maritech® Synergy, a fucoidan seaweed extract, and L. plantarum L-137 (Immuno-LP20®), a stable, heat-treated immunobiotic.* Together they support healthy lung and respiratory function, healthy gut lining and gut immunity, and significant antioxidant and anti-inflammatory activity.

Suggested use: As a dietary supplement, 1 capsule daily, preventatively, or 3-6 per day in a treatment mode. May be taken with or without food.